The Nanomedicine and Extracellular Vesicles Laboratory of Joy Wolfram, Ph.D., at Mayo Clinic in Jacksonville, Florida, focuses on nanomedicine to develop new strategies for the treatment and diagnosis of disease.
In particular, Dr. Wolfram is leading research to develop extracellular vesicle therapeutics and diagnostics for inflammatory conditions and methods for organotropic drug delivery. Our lab is developing new treatments and biomarkers for metastatic breast cancer and various forms of cardiovascular disease.
Nanotechnology enables the design of multifunctional and targeted therapies, thereby increasing therapeutic efficacy and reducing side effects of treatment for breast cancer, cardiovascular disease and other conditions.
Dr. Wolfram's ultimate goal is to bring new nanomedicine treatments to clinical practice at Mayo Clinic. She also aspires to generate fruitful interinstitutional research collaborations around the world with researchers also focusing on extracellular vesicles, microvesicles, drug delivery, nanodelivery and nanotechnology. Considered an emerging researcher to watch, Dr. Wolfram is an assistant professor of medicine at Mayo Clinic College of Medicine and Science in Jacksonville, Florida.